Caballero Francisco, Lopez-Navidad Antonio, Cotorruelo Julio, Txoperena Gabriel
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Transplantation. 2002 Aug 27;74(4):532-7. doi: 10.1097/00007890-200208270-00017.
Ecstasy is a neurotoxic and hepatotoxic drug. Brain edema and fulminant hepatic failure are two of the most serious complications associated with the consumption of ecstasy. Acute ecstasy intoxication can transform a patient into an organ donor or a hepatic graft recipient.
In the last 5 years in our centers, we have had two multiorgan donors who died from ecstasy-induced brain edema and three patients who required urgent orthotopic liver transplantation for treatment of severe acute hepatocellular failure induced by this drug. We performed eight transplantations using the organs of these two brain-dead donors: one heart, one bipulmonary, three kidneys, one kidney-pancreas, and two livers.
Toxicity caused by ecstasy was not observed in any of the eight patients who underwent transplantation. The clinical state and the graft function of the heart, two liver, renopancreatic, and three kidney recipients were normal for a follow-up period that ranged between 7 months and 4.5 years. The lung recipient died from multiorgan failure secondary to bilateral pneumonia 5 days after the transplantation, and one of the kidney transplant patients died as a result of intestinal lymphoma 6 months after transplantation. The three liver transplantations in the three patients with ecstasy-induced fulminant hepatic failure were performed successfully using orthotopic transplantation. These three recipients are asymptomatic and have normal-functioning hepatic grafts after follow-up of 3.5 years, 15 months, and 11 months, respectively.
The thoracic and abdominal organs of people dying from ecstasy intoxication can be viable for transplantation. The short- and medium-term survival of the graft and of the recipient have been similar to that of other organ donors. Urgent liver transplantation is an effective therapeutic option in patients with ecstasy-induced acute hepatocellular failure.
摇头丸是一种具有神经毒性和肝毒性的药物。脑水肿和暴发性肝衰竭是与服用摇头丸相关的两种最严重的并发症。急性摇头丸中毒可使患者成为器官捐献者或肝移植受者。
在过去5年里,我们中心有两名多器官捐献者死于摇头丸所致的脑水肿,还有三名患者因该药物引起的严重急性肝细胞衰竭而需要紧急进行原位肝移植。我们使用这两名脑死亡捐献者的器官进行了8例移植手术:1例心脏、1例双肺、3例肾脏、1例肾胰联合移植以及2例肝脏移植。
接受移植的8例患者中均未观察到摇头丸引起的毒性反应。心脏、2例肝脏、肾胰联合移植以及3例肾脏移植受者的临床状况和移植器官功能在7个月至4.5年的随访期内均正常。肺移植受者在移植后5天死于双侧肺炎继发的多器官功能衰竭,1例肾移植患者在移植后6个月因肠道淋巴瘤死亡。对3例因摇头丸导致暴发性肝衰竭的患者成功进行了原位肝移植。这三名受者分别在随访3.5年、15个月和11个月后均无症状,移植肝脏功能正常。
死于摇头丸中毒者的胸腹部器官可用于移植。移植器官和受者的短期及中期存活率与其他器官捐献者相似。紧急肝移植是治疗摇头丸所致急性肝细胞衰竭患者的有效治疗选择。